YONSA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is Abiraterone Acetate.
Product ID | 47335-401_017c925b-42af-4c17-971a-4cc9dbe089a1 |
NDC | 47335-401 |
Product Type | Human Prescription Drug |
Proprietary Name | YONSA |
Generic Name | Abiraterone Acetate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2018-05-22 |
Marketing Category | NDA / NDA |
Application Number | NDA210308 |
Labeler Name | Sun Pharmaceutical Industries, Inc. |
Substance Name | ABIRATERONE ACETATE |
Active Ingredient Strength | 125 mg/1 |
Pharm Classes | Cytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2018-05-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA210308 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-05-22 |
Ingredient | Strength |
---|---|
ABIRATERONE ACETATE | 125 mg/1 |
SPL SET ID: | b8967e10-f768-47ce-ac9e-2324c8390132 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
47335-401 | YONSA | abiraterone acetate |
0143-9597 | Abiraterone | Abiraterone acetate |
0093-1125 | Abiraterone Acetate | Abiraterone Acetate |
0378-6920 | Abiraterone Acetate | abiraterone acetate |
0378-6921 | Abiraterone Acetate | abiraterone acetate |
0378-6924 | Abiraterone Acetate | abiraterone acetate |
0904-6948 | Abiraterone Acetate | Abiraterone Acetate |
16714-963 | Abiraterone Acetate | Abiraterone Acetate |
42292-057 | Abiraterone Acetate | abiraterone acetate |
43598-358 | Abiraterone Acetate | Abiraterone Acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
YONSA 86757216 5317612 Live/Registered |
SUN PHARMA GLOBAL FZE 2015-09-15 |